title: Vibunazole and its enantiomers. Synthesis, antifungal activity, and pharmacokinetics.
authors.affiliation: Pharmaceutical Research Center, Bayer AG, Wuppertal, Federal Republic of Germany.
authors.forename: W
authors.initials: W
authors.lastname: Ritter
authors.forename: G
authors.initials: G
authors.lastname: Holmwood
authors.forename: H J
authors.initials: HJ
authors.lastname: Ahr
authors.forename: K
authors.initials: K
authors.lastname: Detzer
authors.forename: U
authors.initials: U
authors.lastname: Kraatz
authors.forename: M
authors.initials: M
authors.lastname: Plempel
authors.forename: D
authors.initials: D
authors.lastname: Scherling
authors.forename: H M
authors.initials: HM
authors.lastname: Siefert
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects; D007536:Isomerism; D008826:Microbial Sensitivity Tests; D015394:Molecular Structure; D013329:Structure-Activity Relationship; D014230:Triazoles / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000633:toxicity
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; C037494:vibunazole